SJOGREN SYNDROME
Clinical trials for SJOGREN SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SJOGREN SYNDROME trials appear
Sign up with your email to follow new studies for SJOGREN SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for Sjogren's sufferers in major trial
Disease control OngoingThis study tests a drug called ianalumab in people with active Sjogren's syndrome, an autoimmune disease causing dry eyes and mouth. About 500 adults will receive either the drug or a placebo to see if it reduces disease activity and symptoms over 48 weeks. The goal is to find a …
Matched conditions: SJOGREN SYNDROME
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 05:23 UTC
-
New drug shows promise for Sjogren's sufferers in major trial
Disease control OngoingThis study tests a drug called ianalumab in people with active Sjogren's syndrome, an autoimmune disease that causes dry eyes and mouth. About 276 adults with a recent diagnosis will receive either the drug or a placebo. The goal is to see if ianalumab can reduce disease activity…
Matched conditions: SJOGREN SYNDROME
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
Pregnancy study for rare diseases cancelled before it began
Knowledge-focused TerminatedThis study planned to follow women with rare autoimmune diseases (like lupus or arthritis) through pregnancy to learn about complications and improve care. It was withdrawn before any participants enrolled, so no results are available. The goal was to gather information to help d…
Matched conditions: SJOGREN SYNDROME
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 26, 2026 05:25 UTC